Status:
COMPLETED
Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
Brief Summary
This protocol allows for ongoing data collection to assess the long-term clinical and psychosocial outcomes of pediatric patients who have received a hematopoietic stem cell transplant at St. Jude Chi...
Detailed Description
The purpose of this protocol is to provide ongoing data collection and review of long-term outcome and late effects in a large cohort of St. Jude Children's Research Hospital autologous and allogeneic...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- St. Jude patients actively monitored in the BMT-AFU clinic after receiving HSC transplant for a malignant or non-malignant condition.
- St. Jude alumnus who has received a hematopoietic stem cell transplant for a malignant or non-malignant condition and is monitored by the Tumor Registry
Exclusion
Key Trial Info
Start Date :
November 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 3 2022
Estimated Enrollment :
637 Patients enrolled
Trial Details
Trial ID
NCT00674882
Start Date
November 7 2019
End Date
October 3 2022
Last Update
December 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105